{
    "2019-02-11": [
        [
            {
                "time": "2018-02-05",
                "original_text": "Is a Disappointment in Store for Incyte (INCY) Q4 Earnings?",
                "features": {
                    "keywords": [
                        "Disappointment",
                        "INCY",
                        "Q4 Earnings"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-12",
                "original_text": "The roots of “servant leadership” management culture date back to Hermann Hesse and a young Hillary Clinton",
                "features": {
                    "keywords": [
                        "servant leadership",
                        "management culture",
                        "Hermann Hesse",
                        "Hillary Clinton"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-02-28",
                "original_text": "Ligand (LGND) Beats on Q4 Earnings & Sales, Raises '19 View",
                "features": {
                    "keywords": [
                        "Ligand",
                        "LGND",
                        "Q4 Earnings",
                        "Sales",
                        "Raises '19 View"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-15",
                "original_text": "Incyte Down as FDA Extends Review Period of Jakafi for GVHD",
                "features": {
                    "keywords": [
                        "Incyte",
                        "FDA",
                        "Jakafi",
                        "GVHD",
                        "Review Period"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-07",
                "original_text": "Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Tilray",
                        "TLRY",
                        "Q4 Earnings"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-02-20",
                "original_text": "[$$] Big Pharma’s Big Cancer Hope Is Fizzling",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "Cancer Hope",
                        "Fizzling"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}